What’s the best management for a 77‑year‑old woman with overt primary hypothyroidism (TSH >50 µIU/mL, low free T4) and normal ACTH and cortisol?

Immediate Levothyroxine Initiation for Overt Primary Hypothyroidism

Start levothyroxine 25–50 mcg daily immediately for this 77-year-old woman with overt primary hypothyroidism (TSH >50 µIU/mL, free T4 0.05 ng/dL), using a low starting dose due to her age and potential cardiac risk. 1

---

Confirm the Diagnosis

• TSH >50 µIU/mL with free T4 of 0.05 ng/dL (severely low) confirms overt primary hypothyroidism requiring immediate treatment regardless of symptoms 1
• The ACTH 37.1 pg/mL and cortisol 13.9 µg/dL are within normal ranges, making concurrent adrenal insufficiency unlikely 1, 2
• However, before starting levothyroxine in any patient with severe hypothyroidism, you must exclude adrenal insufficiency because thyroid hormone accelerates cortisol metabolism and can precipitate adrenal crisis 1, 2
• In this case, the morning cortisol of 13.9 µg/dL is reassuring (normal range typically 7–25 µg/dL), but if there were any clinical suspicion (hypotension, hyponatremia, unexplained symptoms), perform a cosyntropin stimulation test before initiating levothyroxine 1, 2, 3

---

Initial Levothyroxine Dosing Strategy

For patients >70 years or with any cardiac disease/multiple comorbidities, start levothyroxine at 25–50 mcg daily and titrate gradually by 12.5–25 mcg every 6–8 weeks. 1

• Do not use full replacement dosing (1.6 mcg/kg/day) in elderly patients because rapid normalization can unmask cardiac ischemia, precipitate arrhythmias (especially atrial fibrillation), or worsen heart failure 1
• The rationale for low-dose initiation: elderly patients with underlying coronary disease are at increased risk of cardiac decompensation even with therapeutic levothyroxine doses 1
• Start at 25 mcg daily if there is known cardiac disease, recent cardiac events, or significant frailty 1
• Start at 50 mcg daily if the patient is relatively healthy for her age with no known cardiac disease 1

---

Monitoring Protocol

Recheck TSH and free T4 in 6–8 weeks after starting levothyroxine, then after each dose adjustment. 1

• This 6–8 week interval is mandatory because levothyroxine requires this time to reach steady-state concentrations 1
• Target TSH: 0.5–4.5 mIU/L with normal free T4 1
• Continue dose adjustments by 12.5–25 mcg increments every 6–8 weeks until TSH normalizes 1
• Once stable, monitor TSH every 6–12 months or sooner if symptoms change 1

---

Critical Safety Considerations

Rule Out Adrenal Insufficiency First

• Never start thyroid hormone before ruling out adrenal insufficiency in suspected central hypothyroidism or in patients with autoimmune hypothyroidism who may have concurrent autoimmune adrenal disease 1, 3
• In this patient, the normal ACTH and cortisol make adrenal insufficiency unlikely, but remain vigilant for symptoms 1, 2
• If adrenal insufficiency is identified, start hydrocortisone 20 mg morning/10 mg afternoon for at least one week before initiating levothyroxine 1

Monitor for Cardiac Complications

• Assess for new or worsening angina, palpitations, dyspnea, or arrhythmias at each follow-up 1
• Obtain an ECG to screen for baseline arrhythmias, especially atrial fibrillation 1
• If cardiac symptoms develop, reduce the levothyroxine dose and reassess more frequently 1

Avoid Overtreatment

• Approximately 25% of patients on levothyroxine are unintentionally overtreated with TSH suppression (<0.1 mIU/L), which increases risk for atrial fibrillation (3–5 fold), osteoporosis, fractures, and cardiovascular mortality 1
• If TSH falls below 0.1 mIU/L, reduce levothyroxine by 25–50 mcg immediately 1
• If TSH is 0.1–0.45 mIU/L, reduce by 12.5–25 mcg, especially in elderly or cardiac patients 1

---

Expected Clinical Outcomes

Treatment with levothyroxine will:

• Resolve hypothyroid symptoms (fatigue, weight gain, cold intolerance, constipation, cognitive slowing) within 6–8 weeks 1
• Improve cardiovascular function by normalizing cardiac output, reducing systemic vascular resistance, and correcting diastolic dysfunction 1
• Lower LDL cholesterol and improve lipid profile 1
• Prevent progression of cardiac dysfunction and reduce cardiovascular event risk 1

---

Common Pitfalls to Avoid

1. Starting at full replacement dose in elderly patients – this can precipitate myocardial infarction, heart failure, or fatal arrhythmias 1
2. Adjusting doses too frequently before steady state – wait 6–8 weeks between adjustments 1
3. Failing to recognize transient hypothyroidism – confirm elevated TSH with repeat testing, as 30–60% normalize spontaneously (though with TSH >50 and low T4, this is clearly overt disease requiring treatment) 1
4. Missing concurrent adrenal insufficiency – always assess cortisol/ACTH before starting levothyroxine in severe hypothyroidism 1, 2, 3
5. Overlooking cardiac risk factors – elderly patients require more conservative dosing and closer cardiac monitoring 1

---

Special Considerations for This Patient

• Age 77 years mandates low-dose initiation (25–50 mcg daily) regardless of other factors 1
• The severely elevated TSH (>50 µIU/mL) and very low free T4 (0.05 ng/dL) indicate profound hypothyroidism requiring treatment, but the elderly age necessitates gradual titration 1
• If this patient were planning pregnancy, more aggressive normalization would be warranted, but at age 77 this is not a consideration 1, 4
• Monitor for improvement in quality of life, energy, cognition, and cardiovascular symptoms as levothyroxine is titrated 1